Resonetics said it has acquired the manufacturing assets, process know-how, and intellectual property related to implantable and external pulse generators (IPG/EPG) and leads manufacturing and assembly from Med-Ally, a medical technology design and development company focused on the neuromodulation market.
The acquisition strengthens Resonetics’ Medical Power business by combining its implantable battery technologies with advanced pulse generator manufacturing processes. This integration enables Resonetics to offer customers another solution, from energy source to active implantable device, serving the expanding neuromodulation, brain-computer-interface (BCI), and cardiac rhythm management (CRM) markets. As part of the deal, the acquired assets will ultimately be transferred to an existing Resonetics facility.
The acquisition marks the third notable transaction for Resonetics in the last 12 months, having added nitinol gun-drilling and insert- and micro-molding with the prior acquisitions of select assets from Medical Component Specialists and Eden Holdings. The company will continue to target niche manufacturing technologies that support its focus on the most innovative market segments within the medical device industry.
